These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 1319383)

  • 21. Morphologic, immunohistochemical, and fluorescence in situ hybridization study of ovarian embryonal carcinoma with comparison to solid variant of yolk sac tumor and immature teratoma.
    Cheng L; Zhang S; Talerman A; Roth LM
    Hum Pathol; 2010 May; 41(5):716-23. PubMed ID: 20096442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perspectives on testicular germ cell neoplasms.
    Cheng L; Lyu B; Roth LM
    Hum Pathol; 2017 Jan; 59():10-25. PubMed ID: 27569298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of intraoperative imprint cytology in ovarian germ cell tumors.
    Abe A; Sugiyama Y; Furuta R; Furuta N; Matoda M; Takeshima N
    Acta Cytol; 2013; 57(2):171-6. PubMed ID: 23406948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ovarian mixed germ cell tumor with yolk sac and teratomatous components in a dog.
    Robinson NA; Manivel JC; Olson EJ
    J Vet Diagn Invest; 2013 May; 25(3):447-52. PubMed ID: 23604259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha-fetoprotein in malignant germ cell tumors of the ovary.
    Kawai M; Furuhashi Y; Kano T; Misawa T; Nakashima N; Hattori S; Okamoto Y; Kobayashi I; Ohta M; Arii Y
    Gynecol Oncol; 1990 Nov; 39(2):160-6. PubMed ID: 1699854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CA19-9 may have clinical significance in mature cystic teratomas of the ovary.
    Dede M; Gungor S; Yenen MC; Alanbay I; Duru NK; Haşimi A
    Int J Gynecol Cancer; 2006; 16(1):189-93. PubMed ID: 16445632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malignant transformation of mature cystic teratoma of the ovary including three cases occurring during follow-up period.
    Yamaguchi K; Mandai M; Fukuhara K; Higuchi T; Hamanishi J; Takakura K; Fujii S
    Oncol Rep; 2008 Mar; 19(3):705-11. PubMed ID: 18288405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mixed germ cell tumours of the ovary in childhood and adolescence].
    Zuntová A; Sumerauer D; Teslík L; Kabícková E; Koutecký J
    Cesk Patol; 2004 Jul; 40(3):92-101. PubMed ID: 15493415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary juxtaovarian yolk sac tumor concurrent with an ipsilateral ovarian mature teratoma in an adult woman: a rare association.
    Ma H; Yu J; Tang J; Wang M
    Int J Clin Exp Pathol; 2015; 8(1):1046-9. PubMed ID: 25755817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Teratoma of the ovary. Clinical and pathological differences between mature and immature teratomas].
    Schmidt D; Kommoss F
    Pathologe; 2007 May; 28(3):203-8. PubMed ID: 17396268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epithelial-mesenchymal transition markers in malignant ovarian germ cell tumors.
    Solheim O; Førsund M; Tropé CG; Kraggerud SM; Nesland JM; Davidson B
    APMIS; 2017 Sep; 125(9):781-786. PubMed ID: 28585395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Germ cell tumours.
    Talerman A
    Ann Pathol; 1985; 5(3):145-57. PubMed ID: 3000396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The pathology of germ cell tumors of the ovary].
    Ishikawa E
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2479-88. PubMed ID: 6095759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of cyclooxygenase-2 in ovarian mature cystic teratomas with malignant transformation.
    Sumi T; Ishiko O; Yoshida H; Hyun Y; Nakagawa E; Hirai K; Matsumoto Y; Ogita S
    Int J Mol Med; 2001 Nov; 8(5):495-8. PubMed ID: 11605016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ovarian germ cell tumors in girls].
    Nechushkina IV; Karseladze AI
    Vopr Onkol; 2015; 61(2):239-43. PubMed ID: 26087605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Teratoma with malignant transformation: experiences of the cooperative GPOH protocols MAKEI 83/86/89/96.
    Biskup W; Calaminus G; Schneider DT; Leuschner I; Göbel U
    Klin Padiatr; 2006; 218(6):303-8. PubMed ID: 17080331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The value of cancer antigen-125 as a tumor marker in malignant germ cell tumors of the ovary.
    Altaras MM; Goldberg GL; Levin W; Darge L; Bloch B; Smith JA
    Gynecol Oncol; 1986 Oct; 25(2):150-9. PubMed ID: 2428701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. OCT4 staining in testicular tumors: a sensitive and specific marker for seminoma and embryonal carcinoma.
    Jones TD; Ulbright TM; Eble JN; Baldridge LA; Cheng L
    Am J Surg Pathol; 2004 Jul; 28(7):935-40. PubMed ID: 15223965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ovarian mucinous tumors arising from mature cystic teratomas--a molecular genetic approach for understanding the cellular origin.
    Fujii K; Yamashita Y; Yamamoto T; Takahashi K; Hashimoto K; Miyata T; Kawai K; Kikkawa F; Toyokuni S; Nagasaka T
    Hum Pathol; 2014 Apr; 45(4):717-24. PubMed ID: 24485845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinicopathological study of malignant ovarian germ cell tumor].
    Kataoka A; Yakushiji M; Nishida T; Oda T; Kojiro M
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jun; 41(6):695-701. PubMed ID: 2549132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.